332 related articles for article (PubMed ID: 27729526)
21. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
Luo X; Li M; Su B
Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
[TBL] [Abstract][Full Text] [Related]
22. Dramatic Improvement of CRISPR/Cas9 Editing in
Ng H; Dean N
mSphere; 2017; 2(2):. PubMed ID: 28435892
[TBL] [Abstract][Full Text] [Related]
23. Application of CRISPR/Cas9 to Tragopogon (Asteraceae), an evolutionary model for the study of polyploidy.
Shan S; Mavrodiev EV; Li R; Zhang Z; Hauser BA; Soltis PS; Soltis DE; Yang B
Mol Ecol Resour; 2018 Nov; 18(6):1427-1443. PubMed ID: 30086204
[TBL] [Abstract][Full Text] [Related]
24. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
[TBL] [Abstract][Full Text] [Related]
25. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
26. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells.
Seki A; Rutz S
J Exp Med; 2018 Mar; 215(3):985-997. PubMed ID: 29436394
[TBL] [Abstract][Full Text] [Related]
27. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
28. Efficiency Optimization of CRISPR/Cas9-Mediated Targeted Mutagenesis in Grape.
Ren F; Ren C; Zhang Z; Duan W; Lecourieux D; Li S; Liang Z
Front Plant Sci; 2019; 10():612. PubMed ID: 31156675
[TBL] [Abstract][Full Text] [Related]
29. Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line.
Dehler CE; Boudinot P; Martin SA; Collet B
Mar Biotechnol (NY); 2016 Aug; 18(4):449-52. PubMed ID: 27236514
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass.
Wang X; Niu Y; Zhou J; Zhu H; Ma B; Yu H; Yan H; Hua J; Huang X; Qu L; Chen Y
Anim Genet; 2018 Feb; 49(1):43-51. PubMed ID: 29446146
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
33. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
34. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
35. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
36. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies.
Nüssing S; House IG; Kearney CJ; Chen AXY; Vervoort SJ; Beavis PA; Oliaro J; Johnstone RW; Trapani JA; Parish IA
J Immunol; 2020 Apr; 204(8):2308-2315. PubMed ID: 32152070
[TBL] [Abstract][Full Text] [Related]
37. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
[TBL] [Abstract][Full Text] [Related]
38. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
Du QS; Cui J; Zhang CJ; He K
J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
[TBL] [Abstract][Full Text] [Related]
39. CRISPRed Macrophages for Cell-Based Cancer Immunotherapy.
Ray M; Lee YW; Hardie J; Mout R; Yeşilbag Tonga G; Farkas ME; Rotello VM
Bioconjug Chem; 2018 Feb; 29(2):445-450. PubMed ID: 29298051
[TBL] [Abstract][Full Text] [Related]
40. Efficient Generation of Genome-Modified Mice Using Campylobacter jejuni-Derived CRISPR/Cas.
Fujii W; Ikeda A; Sugiura K; Naito K
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
